About us

Company Milestones

  • 1989

    Peter Ford identifies damaged muscles still emit electrical signals.

  • 1998–2000

    First clinical trials on patients using EMG signals, Houston Hospital, Texas

    Peter Ford meets James Schorey and begins work on Neuroswitch EMG concept and hardware.

  • 2001–2003

    Stephen Hawking uses Neuroswitch technology for the first time to control his wheelchair.

  • 2003–2004

    Shane Coburn successfully uses Neuroswitch after bus accident in New Zealand leaves him a quadriplegic.

    Control Bionics is incorporated. First international patents lodged and first sale.

  • 2005

    French Physicist, Roger Caravon, suffering from ALS, starts using Neuroswitch.

  • 2006

    New pocket-sized Neuroswitch educator and improved G3 software launched.

  • 2007

    USA Veterans’ Association approves full funding of Neuroswitch. Professor Nick Rowe, world authority on MND and Parkinson’s Disease, endorses CB technology and assists with R&D.

  • 2007

    Gary Griffin USAF (Ret) is first funded VA recipient of Neuroswitch. Dallas PD SWAT Team Commander, Lt Carlton Marshall, uses Neuroswitch in first months of recovery from a gunshot wound.

  • 2008

    ALS patient, Nick McLoughlin, controls his wheelchair for the first time.

  • 2009

    Cerebral palsy patient, Michael Phillips, uses Neuroswitch to play video games.

  • 2010

    Control Bionics gains USA FDA approval for Neuroswitch.

  • 2011

    US Marine, Carlo Russo, says Neuroswitch saved his life after a heart attack because he could still write love letters to his wife.

  • 2013

    Launch of Bluetooth Neuroswitch with new chip and latest Gen 8 monitoring software.

  • 2014

    Glen Sargood, communicates with his wife for the first time in four years after contracting MND.

    Control Bionics acquires James Schorey’s business, TAI, and its hardware intellectual property. James becomes COO of Control Bionics. Peter Ford nominated for Senior Australian of the Year.

  • 2015

    Janet Abraham, confined by ALS, uses Neuroswitch Bluetooth® to communicate.

    Australia’s National Disability Insurance Scheme (NDIS) approves full funding for Neuroswitch. Peter Ford presents at World Medical Innovation Conference in Boston.

  • 2016

    Control Bionics launches revolutionary NeuroNode wireless communications technology.

Key People and board

Peter Ford Founder and Chairman

For some people, Peter’s face may be familiar from his time as a CNN news anchor. But Peter’s real passion has always been bionics and robotics. In particular, he was inspired by the potential to help free one of the world’s great minds, Stephen Hawking.

In 1989, Peter identified that the patients’ damaged muscles still emitted small electrical signals that could be used to reliably control basic computer functions. And with that, Control Bionics was born.

Rob Wong CEO

Rob is founder and CEO of marketing strategy consultancy Innovat8.com. For Control Bionics, Rob is responsible for our international marketing strategy and operations, working closely with CEO Peter Ford. He has over 25 years experience in multinational advertising and digital marketing agencies. He has also been a successful tech start-up entrepreneur having developed and exited a retail digital media business. He was also CEO of AIMIA Digital Industry Association of Australia. B.Bus Monash University. MBA Mt Eliza Business School.

Lindsay Philips
Lindsay Philips Board Member

As an highly-experienced private equity fund MD and Chairman, Lindsay is key member of the Control Bionics’ leadership team.

Lindsay first invested in Control Bionics in 2005, as Managing Director of Lazard Private Equity Australia. He is now Chairman of Phoenix Development Fund and Nightingale Partners. To continue to refine and advance our technological offering and improve people’s quality of life, the continued funding of research and development is crucial.

James Schorey Chief Operating Officer

Before joining Control Bionics, James was the CEO of Therapeutic Alliances, a manufacturer of a key sub-system of the NeuroNode. When Therapeutic Alliances was acquired by Control Bionics, James became our VP of Engineering. He is responsible for leading our hardware and firmware development and production, as well as managing our Head Office in Milford, Ohio.

Emily Boland Marketing & Social Media Manager

Emily Boland joined Control Bionics is 2013 and is responsible for marketing, brand, pr, customer relations and social media. Previously, Emily worked in the design and packaging industry and as a social media content marketer. She graduated from the University of Cincinnati’s School for Design, Architecture, Art, and Planning (DAAP) with a degree in Digital Design.

+1 (855) 831-7521